Skip To The Main Content
Parenteral Drug Association Connecting People, Science and Regulation ®

Press Releases

PDA GMP for APIs Education Webinar Now an "ICH Recognised Training Programme"

For Immediate Release:
12/04/2019
Media Inquiries:
Walt Morris
/ [email protected] /
301-656-5900, x. 148

Bethesda, Md. – The Parenteral Drug Association (PDA) is proud to announce that its “ICH Q7 GMP for APIs” online training module is now endorsed by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use as an “ICH Recognised Training Programme.” 

The training module received the distinction after PDA demonstrated to ICH that it meets the twelve eligibility criteria for the program. Among these are its mission to serve as a neutral convening platform to engage expert stakeholders from industry, academia, advocacy groups, non-profits, and/or regulatory agencies on critical regulatory topics, and its promotion of regulatory convergence to accelerate innovation and improve healthcare globally.

The free “ICH Q7 GMP for APIs” training module introduces and improves understanding of the ICH quality guideline, Q7: Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. The webinar is intended for pharmaceutical professionals working with APIs.  More information on the webinar is available here: https://www.pda.org/global-event-calendar/ich-q7-gmp-for-apis.